Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function
- 1 September 1992
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 82 (1) , 13-19
- https://doi.org/10.1111/j.1365-2141.1992.tb04587.x
Abstract
Several iron chelators, 3-hydroxypyridin-4-ones (CP) and desferrioxamine (DF) were compared for their effect on DNA synthesis, cell viability and expression of cell proliferation markers. Short-term (4 h) exposure of human peripheral blood mononuclear cells to CP or DF inhibited the proliferative response of cells to concanavalin A (Con A). Inhibition by CP and DF showed a dose-dependent effect with CP compounds more active than DF. Increased inhibitory activity of CP over DF was partly due to the lipophilic properties of CP. Pre-saturation of CP and DF with exogenous ferric ion either diminished or prevented the inhibitory effect. At high chelator concentrations or prolonged (72 h) exposure of the cells to chelators, inhibition occurred but poor cell viability was observed. In contrast to their inhibition of DNA synthesis, these iron chelators showed little effect on protein synthesis and the expression of transferrin receptors and interleukin-2 (IL-2) receptors. These findings suggest that both DF and CP compounds exert their effect by chelation of ferric ion with subsequent inhibition of DNA synthesis.Keywords
This publication has 26 references indexed in Scilit:
- Ferritin synthesis in peripheral blood lymphocytes following in vitro stimulation*European Journal of Haematology, 2009
- ANIMAL TOXICOLOGY OF IRON CHELATOR L1The Lancet, 1989
- Effect of phytohaemagglutinin on the synthesis and secretion of ferritin in peripheral blood lymphocytesBritish Journal of Haematology, 1988
- Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.BMJ, 1987
- NEW ORALLY ACTIVE IRON CHELATORSThe Lancet, 1985
- Uptake and release of transferrin and iron by mitogen-stimulated human lymphocytesBritish Journal of Haematology, 1983
- Clinical Consequences of Acquired Transfusional Iron Overload in AdultsNew England Journal of Medicine, 1981
- Effect of Iron Deficiency and Desferrioxamine on DNA Synthesis in Human CellsBritish Journal of Haematology, 1976
- Inhibition of ribonucleoside diphosphate reductase by 1-formylisoquinoline thiosemicarbazone and related compoundsBiochemistry, 1970
- The Biochemistry of Desferrioxamine and its Relation to Iron MetabolismAnnals of the New York Academy of Sciences, 1964